HEALTHCARE

The Ministry of Health has confirmed that salmonella was present in a batch of Tnuva milk powder, but says the product was not sold to the public.

GE Healthcare will invest up to $50 million in the Israeli home ultrasound devices company and will distribute pregnancy monitoring products.

The Israeli company's precision oncology diagnostic solution is expected to launch commercially in the US in the third quarter of 2022.

The state claims that Teva violated IP rights in the development of the longer interval dosage version of the multiple sclerosis drug.

Bioventus has announced that it has canceled the $415 million it planned to raise to finance the acquisition, due to market conditions.

The Israeli company has developed the RENOVA iStim implantable tibial neuromodulation device under investigation for the treatment of incontinence and overactive bladder (OAB).

Israel will stop requiring passengers landing at Ben Gurion airport and entering Israel to undergo PCR testing from Friday, May 20, the Health Ministry has announced.

The Israeli healthcare investment platform has already raised half of the sum with Philips Healthcare as lead investor.

Imagene's digitized biopsy image AI diagnostic technology delivers real-time molecular analysis, increasing the level of accuracy and reducing the time required for results, from several weeks to just two minutes.

The Israeli pharmaceutical company has cut 2022 revenue guidance.

The Israeli company's heart disease management system identifies high blood pressure, excessive cholesterol and other phenomena associated with heart disease.

The ability to independently produce iPSC’s, in parallel to the completion of the hydrogel development, is a crucial step towards end-to-end independent manufacturing capacity of neural tissue implants.

GDA-201 is an off-the-shelf cell therapy candidate for the treatment of patients with follicular and diffuse large B cell lymphomas.

Set-up costs are soaring, and conditions at the multinationals are just too good.

With new Covid infections on the wane, the requirement to wear masks in enclosed spaces will be canceled from Saturday night, April 23, at 8pm.

Teva and its French partner MedinCell have received a Complete Response Letter, meaning that the New Drug Application cannot be approved in its present form.

Israeli government policy is that foreign tourists who test positive for Covid must be accommodated in a government-run Covid hotel.

Teva VP Ukraine, Africa, and Middle East Yossi Ofek, who also manages Teva Israel, explains why Teva has launched operations in countries global pharma companies avoid, and insists Teva remains committed to Israel.

The companies will collaborate on a project using Dotz Nano's technology for marking disposable bioprocessing consumables.

EPM front man Prof. Zeev Rotstein: Apparently we managed to annoy someone.

Businessman and former Air Force pilot Stibbe is part of the first commercial space mission by Axiom Space.

To date LionBird has invested in more than 30 digital health companies.

The company has pioneered the use of AI algorithms and machine learning to increase the speed of diagnosis and care for a variety of diseases in hospitals and health systems.

The cost of the measures to the taxpayer is estimated at NIS 320 million over four years.

US orthologics company Bioventus is acquiring the Israeli cartilage implants company for $350 million, plus $150 million from future revenue.

Teva will pay Florida $177 million over 15 years and provide opioid overdose treatments worth $84 million over 10 years.

It is not yet known whether Prime Minister Naftali Bennett will make his planned official visit to India at the end of the week.

Studies by the Clalit and Maccabi health funds have found that four vaccine doses give considerably better protection than three.

The company has set up NTT Innovation Laboratory Israel to collaborate with local startups and academic institutions.

Nucleai is an AI-powered spatial biology company, which seeks to transform drug development and clinical treatment decisions through pathology data.